(Q45040086)

8 December 2017

Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates (English)

1 reference

8 December 2017

1 reference

Decamp E

1

1 reference

PubMed ID

15341609

8 December 2017

Schneider JS

series ordinal

2

1 reference

PubMed ID

15341609

8 December 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

European Journal of Neuroscience

8 December 2017

1 reference

8 December 2017

20

1 reference

8 December 2017

5

1 reference

8 December 2017

1371-1378

1 reference

Executive functioning, temporal discounting, and sense of time in adolescents with attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD).

8 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Attentional cueing reverses deficits in spatial working memory task performance in chronic low dose MPTP-treated monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Frontal lobe and frontal-striatal substrates for different forms of human cognitive flexibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Spatial behaviour is driven by proximal cues even in mildly impaired Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Assessment of cognition in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Dissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Spatial and non-spatial working memory at different stages of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

How do the parietal lobes direct covert attention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

The Subtype-Selective Nicotinic Acetylcholine Receptor Agonist SIB-1553A Improves Both Attention and Memory Components of a Spatial Working Memory Task in Chronic Low Dose 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Executive function profile of children with attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Distractibility in early Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Clinical psychopharmacology of AD/HD: implications for animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Effects of altering brain cholinergic activity on covert orienting of attention: comparison of monkey and human performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

Alteration of brain noradrenergic activity in rhesus monkeys affects the alerting component of covert orienting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2004.03586.X

10.1111/J.1460-9568.2004.03586.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference

PubMed ID

15341609